查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717769

转染技术市场（按产品、方法、应用和最终用户划分）—2025-2030 年全球预测

Transfection Technologies Market by Product, Method, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计转染技术市场规模在 2024 年将达到 12.6 亿美元，在 2025 年将达到 13.7 亿美元，在 2030 年将达到 20.8 亿美元，复合年增长率为 8.60%。

主要市场统计数据
基准年2024年 12.6亿美元
预计2025年 13.7亿美元
预测年份 2030 20.8亿美元
复合年增长率（%） 8.60%

转染技术领域在过去的几十年中取得了长足的进步，从传统的协议发展到塑造现代研究和临床应用的复杂自动化解决方案。本报告介绍了转染技术在各种研究和治疗环境中的动态情况。在分子生物学多学科进步和创新融合的推动下，市场正在经历快速变化，重新定义基因传递和表达的方式。在以高精度科学探索和强大的数位转型为特征的时代，研究人员和相关人员不断寻找改进转染程序的方法，使其更有效率、可重复、更安全。在此背景下，新趋势正在推动市场朝向更加整合、更具成本效益的解决方案迈进，预计将提高吞吐量。这种动态格局为新策略、加强品管和基因工程的突破性方法提供了肥沃的土壤，使转染技术市场成为更大的生物技术生态系统中的关键部分。

新方法和新设备的日益普及反映了该领域为克服基因转移中长期存在的挑战所做的努力。在学术界和工业实验室的大力支持下，转染技术现在被誉为具有简化基因编辑过程、缩短研究时间并在治疗开发中提供个人化解决方案的潜力。该领域的进步不仅巩固了其当前的重要性，也展示了市场长期成长和创新的潜力。

改变转染技术市场

转染技术的演化以变革性的变化为标誌，这些变化正在重塑整体情况。近年来，随着数位自动化、机器人技术和高通量筛检的进步与新型化学和物理转染方法的融合，该行业经历了模式转移。这些转变使研究人员能够达到前所未有的精确度和效率，同时减少实验程序所需的时间和资源。这种变化不仅仅是技术上的；这也意味着对传统上定义我们产业的方法进行策略性的重新思考。

自动化和小型化的进步为更可靠和可重复的转染结果铺平了道路，使实验室能够扩大业务规模，同时提高品质和成本效益。除了这些技术进步之外，人工智慧和机器学习的整合还简化了协议优化并提供即时数据分析和预测见解，有助于降低与实验室差异相关的风险。随着业界逐渐转向更客製化的解决方案，人们越来越重视采用一种多功能且强大的方法，以便转染通讯协定能够精确地适应特定的实验需求。总体而言，这里强调的转变代表了转染技术发展的重大飞跃，并为继续投资和研究这一创新领域提供了令人信服的案例。

推动市场动态的关键细分洞察

转染技术市场的细分为理解市场的微妙动态提供了一个全面的框架。基于产品的细分将市场区分为仪器和试剂/试剂套件，每种产品在确定基因转移的准确性和效率方面都发挥着至关重要的作用。结合以方法为基础的细分，市场进一步分为生物、化学和物理转染技术。生物学部分重点在于质体DNA 和病毒载体，深入分析突显其独特的优势和挑战。同样，在化学转染领域，磷酸钙转染和脂质转染成为亮点，凸显了简单性和高效性的平衡。物理转染方法专注于基因枪、电穿孔和显微注射等先进方法，每种方法都为特定应用提供客製化的解决方案。

此外，基于应用的细分涵盖细胞株开发、CRISPR 和基因编辑、基因治疗、蛋白质生产和疫苗接种等关键领域。这样的分类突显了技术创新与下游应用之间的直接关係，其中每个领域的需求推动着客製化转染通讯协定的演变。最后，基于最终用户的细分透过关注学术和研究机构、受託研究机构、医院和诊断实验室以及製药和生物技术公司的需求，进一步加深了市场理解。这种分层细分不仅提供了更详细的市场趋势视图，而且使每个细分市场成为整体策略不可或缺的一部分，确保创新具有针对性并满足不同用户的需求。每个细分类别都代表着特定的挑战和机会，从而更深入地了解当前转染技术的多面性。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 提高全球对RNA干扰和基因编辑技术的认识
      • 更加关注复杂疾病的个人化医疗和标靶基因治疗
      • 增加基因治疗和细胞生物学应用的全球研究资金
    • 限制因素
      • 高级转染试剂高成本且缺乏标准化通讯协定
    • 机会
      • 投资与资金筹措激增，推动转染技术发展
      • 转染试剂配方的技术进步提高了效率
    • 任务
      • 严格的监管障碍和安全合规问题正在影响新基因疗法的核准
  • 市场区隔分析
    • 产品：常规应用试剂和套件的需求增加
    • 最终用户：学术和研究机构越来越多地使用转染技术
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 转染技术市场（依产品）

  • 装置
  • 试剂和套件

7. 转染技术市场（依方法）

  • 生物转染
    • 质体DNA
    • 病毒载体
  • 化学转染
    • 磷酸钙转染
    • 脂质体转染
  • 物理转染
    • 基因枪转染/基因枪
    • 电穿孔
    • 显微注射

第八章 转染技术市场（依应用）

  • 细胞株开发
  • CRISPR和基因编辑
  • 基因治疗
  • 蛋白质生产
  • 疫苗接种

第九章 转染技术市场（依最终用户）

  • 学术研究所
  • 合约研究组织（CRO）
  • 医院和诊断实验室
  • 製药和生物技术公司

10. 美洲转染技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第 11 章亚太地区转染技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲转染技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Agilent Technologies, Inc.
  • Akron Biotech LLC
  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • Biomol GmbH
  • Bioneer Corporation
  • Epoch Life Science, Inc.
  • FUJIFILM Wako Pure Chemical Corporation
  • GeneCopoeia Inc.
  • Geno Technology, Inc.
  • Horizon Discovery Group plc by PerkinElmer, Inc.
  • Lonza Group
  • Maxcyte Inc.
  • Merck KGaA
  • Nepa Gene Co., Ltd.
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA by Sartorius AG
  • Polysciences, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reprocell Inc.
  • SignaGen Laboratories LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-B16853779807

The Transfection Technologies Market was valued at USD 1.26 billion in 2024 and is projected to grow to USD 1.37 billion in 2025, with a CAGR of 8.60%, reaching USD 2.08 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.26 billion
Estimated Year [2025] USD 1.37 billion
Forecast Year [2030] USD 2.08 billion
CAGR (%) 8.60%

The field of transfection technologies has witnessed substantial progress over the past decades, evolving from traditional protocols to sophisticated, automated solutions that shape modern research and clinical applications. This report introduces the dynamic environment of transfection techniques deployed in various research and therapeutic settings. Driven by a convergence of interdisciplinary advancements and innovations in molecular biology, the market is experiencing rapid changes that have redefined methods of gene delivery and expression. In an era marked by high-precision scientific inquiry and robust digital transformation, researchers and industrial stakeholders are continuously exploring improved methods to enhance the efficiency, reproducibility, and safety of transfection procedures. In this context, emerging trends are steering the market towards more integrated and cost-effective solutions that promise enhanced throughput. This dynamic landscape provides fertile ground for new strategies, enhanced quality control, and breakthrough approaches in gene manipulation, making the transfection technology market a critical segment within the larger biotechnology ecosystem.

The increasing adoption of novel methodologies and instrumentation reflects the sector's commitment to overcoming longstanding challenges in gene delivery. With a strong push from both academic and industrial laboratories, transfection technologies are now celebrated for their potential to streamline gene editing processes, accelerate research timelines, and offer personalized solutions in therapeutic development. The progress in this sector not only solidifies its current significance but also underlines the market's potential for long-term growth and innovation.

Transformative Shifts in the Transfection Technology Landscape

The evolution of transfection technologies is characterized by transformative shifts that reshape the entire landscape of gene delivery. In recent years, the industry has experienced a paradigm shift as advancements in digital automation, robotics, and high-throughput screening have converged with novel chemical and physical transfection methods. These transformative changes are enabling researchers to achieve unprecedented levels of accuracy and efficiency, while simultaneously reducing the time and resources required for experimental procedures. This shift is not merely technological; it represents a strategic rethinking of methodologies that have traditionally defined the industry.

Advances in automation and miniaturization have paved the way for more reliable and reproducible transfection outcomes, allowing laboratories to scale operations with improved quality and cost-effectiveness. Alongside these technological enhancements, the integration of artificial intelligence and machine learning is streamlining protocol optimization, providing real-time data analytics and predictive insights that help mitigate risks associated with laboratory variability. As the industry moves towards more customized solutions, there is a growing emphasis on adopting approaches that are both versatile and robust, ensuring that transfection protocols can be precisely tuned to meet specific experimental demands. Overall, the transformative shifts discussed here represent a significant leap forward in the evolution of transfection technologies, presenting a compelling case for continued investment and research in this innovative sector.

Key Segmentation Insights Driving Market Dynamics

The segmentation of the transfection technologies market provides a comprehensive framework to understand the nuanced dynamics at play. The product-based segmentation differentiates the market into instruments and reagents and kits, each playing vital roles in determining the precision and efficiency of gene delivery. Coupled with the method-based segmentation, the market is further dissected into biological, chemical, and physical transfection techniques. Within the biological segment, detailed analyses focus on plasmid DNA and viral vectors, emphasizing their unique benefits and challenges. Similarly, the chemical transfection domain is explored through the lens of calcium phosphate transfection and lipofection, underscoring the balance between simplicity and efficiency. For the physical transfection approach, attention is given to advanced methodologies including biolistic transfection often referred to as gene guns, electroporation, and microinjection, each providing tailored solutions for specific applications.

Expanding the framework, application-based segmentation captures key areas such as cell line development, CRISPR and gene editing, gene therapy, protein production, and vaccination. Such categorization highlights the direct relationship between technological innovation and downstream applications, where the demands of each area drive the evolution of tailored transfection protocols. Finally, segmentation based on the end-user further refines market understanding by focusing on the needs of academic and research institutes, contract research organizations, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology companies. This layered segmentation insight not only enables a detailed understanding of market trends but also positions each segment as an integral component of the overall strategy to ensure innovation is contextually relevant and meets diverse user needs. Each segmentation category illustrates specific challenges and opportunities, fostering a deeper appreciation of the multifaceted nature of current transfection technologies.

Based on Product, market is studied across Instruments and Reagents & Kits.

Based on Method, market is studied across Biological Transfection, Chemical Transfection, and Physical Transfection. The Biological Transfection is further studied across Plasmid DNA and Viral Vectors. The Chemical Transfection is further studied across Calcium Phosphate Transfection and Lipofection. The Physical Transfection is further studied across Biolistic Transfection/Gene Guns, Electroporation, and Microinjection.

Based on Application, market is studied across Cell Line Development, CRISPR & Gene Editing, Gene Therapy, Protein Production, and Vaccination.

Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.

Regional Perspectives Shaping Market Trajectories

A regional analysis of transfection technologies reveals distinctive trends and market dynamics across key global regions. In the Americas, robust investment in biopharmaceutical research, coupled with rapid technological adoption in clinical laboratories, is driving significant advancements in transfection protocols. Meanwhile, the Europe, Middle East & Africa region showcases a combination of high regulatory standards and strong industrial R&D initiatives which serve to maintain stability and foster innovation in clinical and academic domains. In Asia-Pacific, dynamic growth is observed as emerging economies invest heavily in establishing sophisticated research infrastructure, thereby accelerating the adoption of state-of-the-art transfection technologies.

Each of these regions contributes uniquely to the overall evolution of the market, illustrating distinct strategic priorities and regulatory environments that influence transfection practices. The interplay between established markets in the Americas and Europe, coupled with the rapid advancements in technologically emerging segments in Asia-Pacific, reflects the global momentum for breakthrough research and clinical applications. A nuanced understanding of these regional insights is critical for stakeholders looking to navigate the complex landscape of transfection technologies and align their strategies with regional strengths and opportunities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights on Leading Companies Influencing Market Innovation

Market leadership in transfection technologies is significantly influenced by a cohort of innovative companies whose continuous research and development efforts have set new benchmarks in the industry. Notable players such as Agilent Technologies, Inc. and Bio-Rad Laboratories, Inc. have showcased their ability to merge cutting-edge instrumentation with robust reagents and kits, transforming traditional gene delivery systems. Companies like Akron Biotech LLC and Altogen Biosystems contribute specialized solutions that address key gaps in efficiency and precision, while Biomol GmbH and Bioneer Corporation underscore the importance of maintaining high-quality standards in product development. Other influential organizations, including Epoch Life Science, Inc. and FUJIFILM Wako Pure Chemical Corporation, are at the forefront of integrating automation with conventional techniques.

Further innovation can be observed from GeneCopoeia Inc. and Geno Technology, Inc., whose focus on developing personalized transfection solutions illustrates the move towards more adaptive and application-specific products. Additionally, industry leaders such as Horizon Discovery Group plc (operating under PerkinElmer, Inc.), Lonza Group, and Maxcyte Inc. are redefining market dynamics by balancing cost-effectiveness with high-performance standards. Companies like Merck KGaA and Nepa Gene Co., Ltd. illustrate the significance of strategic research investments in expanding the repertoire of transfection methodologies across a diverse array of applications. As the market evolves, organizations such as OriGene Technologies, Inc., OZ Biosciences SAS, Polyplus-transfection SA (by Sartorius AG), and Polysciences, Inc. continuously challenge traditional boundaries while Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories LLC, Takara Bio Inc., and Thermo Fisher Scientific, Inc. uphold industry benchmarks through consistent innovation and a commitment to quality. The collective advances made by these industry frontrunners not only enhance overall market competitiveness but also set the tone for future strategic developments in transfection technologies.

The report delves into recent significant developments in the Transfection Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Akron Biotech LLC, Altogen Biosystems, Bio-Rad Laboratories, Inc., Biomol GmbH, Bioneer Corporation, Epoch Life Science, Inc., FUJIFILM Wako Pure Chemical Corporation, GeneCopoeia Inc., Geno Technology, Inc., Horizon Discovery Group plc by PerkinElmer, Inc., Lonza Group, Maxcyte Inc., Merck KGaA, Nepa Gene Co., Ltd., OriGene Technologies, Inc., OZ Biosciences SAS, Polyplus-transfection SA by Sartorius AG, Polysciences, Inc., Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories LLC, Takara Bio Inc., and Thermo Fisher Scientific, Inc.. Actionable Recommendations for Industry Leaders in Transfection Technologies

For industry leaders aiming to capitalize on the evolving transfection technology landscape, several actionable recommendations can serve as essential guidelines. First, invest strategically in research and development to foster technological innovations that address specific challenges such as low transfection efficiency and cytotoxicity. Embracing a multifaceted approach to product development by engaging in cross-functional partnerships-both with academic institutions and other biotechnological entities-can prove to be a decisive factor in maintaining competitive advantages.

Leaders should also consider leveraging data analytics and artificial intelligence tools to refine transfection protocols, ensuring that methods are not only efficient but also tailored to suit diverse application requirements. Integrating new automation technologies and exploring innovative delivery systems should be prioritized to overcome the barriers posed by complex cellular environments. Furthermore, evaluating and revising product portfolios to address evolving market demands will be critical in capitalizing on niche segments. As companies work to expand their footprint across traditional and emerging markets, especially in geographically dynamic regions, attention to quality control and regulatory compliance is paramount. Finally, fostering a culture of continuous improvement and agility will enable organizations to quickly adapt to market disruptions and technological shifts, thereby ensuring sustained growth and improved market positioning in the long run.

Conclusion: Summarizing Core Insights in Transfection Innovations

In summary, the transfection technologies market is experiencing significant evolution driven by technological innovation, rigorous segmentation, and dynamic regional growth. The integration of advanced automation, artificial intelligence, and novel transfection methodologies has created new pathways for enhanced research capabilities and therapeutic applications. As research and clinical applications become increasingly specific and data-driven, there is a growing need to tailor transfection techniques to meet the precise requirements of diverse experimental and therapeutic settings.

The insights derived from detailed segmentation-ranging from product and method distinctions to application and end-user analyses-provide a comprehensive snapshot of the market's multifaceted dynamics. Regional analyses further highlight the unique challenges and opportunities that arise from varying regulatory environments and investment landscapes globally. The combined efforts of key industry players continue to push the envelope on innovation, reinforcing the significance of strategic research partnerships and continuous advancements. Ultimately, the progress in transfection technologies not only promises improved efficiency and reliability but also a broader impact on areas such as gene therapy and protein production, underscoring its pivotal role in the future of biomedical research and clinical treatments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of RNA interference and gene editing techniques globally
      • 5.1.1.2. Growing focus on personalized medicine and targeted gene therapies for complex disorders
      • 5.1.1.3. Increasing global research funding in gene therapy and cellular biology applications
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced transfection reagents and lack of standardized protocols
    • 5.1.3. Opportunities
      • 5.1.3.1. Surging investments & funding to advance transfection technologies
      • 5.1.3.2. Technological advancements in transfection reagent formulations to improve efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory hurdles and safety compliance issues affecting the approval of new gene therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising demand of reagents & kits for routine applications
    • 5.2.2. End-User: Growing use of transfection technologies in academic & research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transfection Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits

7. Transfection Technologies Market, by Method

  • 7.1. Introduction
  • 7.2. Biological Transfection
    • 7.2.1. Plasmid DNA
    • 7.2.2. Viral Vectors
  • 7.3. Chemical Transfection
    • 7.3.1. Calcium Phosphate Transfection
    • 7.3.2. Lipofection
  • 7.4. Physical Transfection
    • 7.4.1. Biolistic Transfection/Gene Guns
    • 7.4.2. Electroporation
    • 7.4.3. Microinjection

8. Transfection Technologies Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Line Development
  • 8.3. CRISPR & Gene Editing
  • 8.4. Gene Therapy
  • 8.5. Protein Production
  • 8.6. Vaccination

9. Transfection Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organizations (CROs)
  • 9.4. Hospitals & Diagnostic Laboratories
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Transfection Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Transfection Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Transfection Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Duoning Biotechnology Group and Branca Bunus collaborate to optimize transient transfection processes for enhanced biopharmaceutical production solutions
    • 13.3.2. STEMCELL Technologies introduces CellPore Transfection System to transform cell transfection and accelerate research in gene therapies and cancer treatments
    • 13.3.3. Merck's signs an agreement to acquire Mirus Bio to strengthen transfection technologies and accelerates viral vector-based gene therapy manufacturing
    • 13.3.4. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
    • 13.3.5. BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
    • 13.3.6. Avectas Launches the Solupore Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Akron Biotech LLC
  • 3. Altogen Biosystems
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomol GmbH
  • 6. Bioneer Corporation
  • 7. Epoch Life Science, Inc.
  • 8. FUJIFILM Wako Pure Chemical Corporation
  • 9. GeneCopoeia Inc.
  • 10. Geno Technology, Inc.
  • 11. Horizon Discovery Group plc by PerkinElmer, Inc.
  • 12. Lonza Group
  • 13. Maxcyte Inc.
  • 14. Merck KGaA
  • 15. Nepa Gene Co., Ltd.
  • 16. OriGene Technologies, Inc.
  • 17. OZ Biosciences SAS
  • 18. Polyplus-transfection SA by Sartorius AG
  • 19. Polysciences, Inc.
  • 20. Promega Corporation
  • 21. Qiagen NV
  • 22. Reprocell Inc.
  • 23. SignaGen Laboratories LLC
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET MULTI-CURRENCY
  • FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET MULTI-LANGUAGE
  • FIGURE 3. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 4. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CALCIUM PHOSPHATE TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLISTIC TRANSFECTION/GENE GUNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CRISPR & GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)

TAB